Serum Albumin to Globulin Ratio is Associated with the Presence and Severity of Inflammatory Bowel Disease

References

• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0
   PubMed Web of Science ®Google Scholar
• Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):390–407. doi:10.1038/ncpgasthep0528
   PubMedGoogle Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–434. doi:10.1038/nature06005
   PubMed Web of Science ®Google Scholar
• Acarturk G, Acay A, Demir K, Ulu MS, Ahsen A, Yuksel S. Neutrophil-to-lymphocyte ratio in inflammatory bowel disease - as a new predictor of disease severity. Bratisl Lek Listy. 2015;116(4):213–217. doi:10.4149/bll_2015_041
   PubMed Web of Science ®Google Scholar
• Bourgonje AR, von Martels JZH, Gabriels RY, et al. A combined set of four serum inflammatory biomarkers reliably predicts endoscopic disease activity in inflammatory bowel disease. Front Med. 2019;6:251. doi:10.3389/fmed.2019.00251
   PubMed Web of Science ®Google Scholar
• Byron C, Cornally N, Burton A, Savage E. Challenges of living with and managing inflammatory bowel disease: a meta-synthesis of patients’ experiences. J Clin Nurs. 2020;29(3–4):305–319. doi:10.1111/jocn.15080
   PubMed Web of Science ®Google Scholar
• Yılmaz B, Köklü S, Yüksel O, Arslan S. Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease. World J Gastroenterol. 2014;20(31):10916–10920. doi:10.3748/wjg.v20.i31.10916
   PubMed Web of Science ®Google Scholar
• Nahon S, Lahmek P, Lesgourgues B, et al. Diagnostic delay in a French cohort of Crohn’s disease patients. J Crohns Colitis. 2014;8(9):964–969. doi:10.1016/j.crohns.2014.01.023
   PubMed Web of Science ®Google Scholar
• Dulai PS, Peyrin-Biroulet L, Danese S, et al. Approaches to integrating biomarkers into clinical trials and care pathways as targets for the treatment of inflammatory bowel diseases. Gastroenterology. 2019;157(4):1032–1043.e1031. doi:10.1053/j.gastro.2019.06.018
   PubMed Web of Science ®Google Scholar
• Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164. doi:10.1093/ecco-jcc/jjy113
   PubMed Web of Science ®Google Scholar
• Buisson A, Gonzalez F, Poullenot F, et al. Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(8):1425–1433. doi:10.1097/MIB.0000000000001140
   PubMed Web of Science ®Google Scholar
• Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008;57(11):1518–1523. doi:10.1136/gut.2007.146357
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol. 2000;95(2):359–367. doi:10.1111/j.1572-0241.2000.t01-1-01790.x
   PubMed Web of Science ®Google Scholar
• Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55(3):426–431. doi:10.1136/gut.2005.069476
   PubMed Web of Science ®Google Scholar
• Sands BE. Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology. 2015;149(5):1275–1285 e1272. doi:10.1053/j.gastro.2015.07.003
   PubMed Web of Science ®Google Scholar
• Gecse KB, Brandse JF, van Wilpe S, et al. Impact of disease location on fecal calprotectin levels in Crohn’s disease. Scand J Gastroenterol. 2015;50(7):841–847. doi:10.3109/00365521.2015.1008035
   PubMed Web of Science ®Google Scholar
• Sonoyama H, Kawashima K, Ishihara S, et al. Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type. J Clin Biochem Nutr. 2019;64(3):265–270. doi:10.3164/jcbn.18-92
   PubMed Web of Science ®Google Scholar
• Boschetti G, Laidet M, Moussata D, et al. Levels of fecal calprotectin are associated with the severity of postoperative endoscopic recurrence in asymptomatic patients with Crohn’s disease. Am J Gastroenterol. 2015;110(6):865–872. doi:10.1038/ajg.2015.30
   PubMed Web of Science ®Google Scholar
• Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16(9):531–543. doi:10.1038/s41575-019-0172-4
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang HE, Bai YM, et al. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut. 2021;70(1):85–91. doi:10.1136/gutjnl-2020-320789
   PubMed Web of Science ®Google Scholar
• Niedziela JT, Hudzik B, Szygula-Jurkiewicz B, et al. Albumin-to-globulin ratio as an independent predictor of mortality in chronic heart failure. Biomark Med. 2018;12(7):749–757. doi:10.2217/bmm-2017-0378
   PubMed Web of Science ®Google Scholar
• Zeng M, Liu Y, Liu F, Peng Y, Sun L, Xiao L. Association between albumin-to-globulin ratio and long-term mortality in patients with chronic kidney disease: a cohort study. Int Urol Nephrol. 2020;52(6):1103–1115. doi:10.1007/s11255-020-02453-7
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454. doi:10.1056/NEJM199902113400607
   PubMed Web of Science ®Google Scholar
• Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229–255. doi:10.2147/IJGM.S102819
   PubMed Web of Science ®Google Scholar
• Hill LA, Bodnar TS, Weinberg J, Hammond GL. Corticosteroid-binding globulin is a biomarker of inflammation onset and severity in female rats. J Endocrinol. 2016;230(2):215–225. doi:10.1530/JOE-16-0047
   PubMed Web of Science ®Google Scholar
• Wu PP, Hsieh YP, Kor CT, Chiu PF. Association between albumin-globulin ratio and mortality in patients with chronic kidney disease. J Clin Med. 2019;8(11):11. doi:10.3390/jcm8111991
   Web of Science ®Google Scholar
• Fong M, Braun KL, Chang RM. Native Hawaiian preferences for informed consent and disclosure of results from genetic research. J Cancer Educ. 2006;21(1 Suppl):S47–52. doi:10.1207/s15430154jce2101s_10
   PubMed Web of Science ®Google Scholar
• Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133(5):1670–1689. doi:10.1053/j.gastro.2007.09.001
   PubMed Web of Science ®Google Scholar
• Ooi CJ, Fock KM, Makharia GK, et al. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol. 2010;25(3):453–468. doi:10.1111/j.1440-1746.2010.06241.x
   PubMed Web of Science ®Google Scholar
• D’Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of Medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132(2):763–786. doi:10.1053/j.gastro.2006.12.038
   PubMed Web of Science ®Google Scholar
• Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11(1):3–25. doi:10.1093/ecco-jcc/jjw168
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980;1(8167):514. doi:10.1016/S0140-6736(80)92767-1
   PubMed Web of Science ®Google Scholar
• Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60(4):505–512. doi:10.1016/S0016-5107(04)01878-4
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–1629. doi:10.1056/NEJM198712243172603
   PubMed Web of Science ®Google Scholar
• Abedin N, Seemann T, Kleinfeld S, et al. Fecal eosinophil cationic protein is a diagnostic and predictive biomarker in young adults with inflammatory bowel disease. J Clin Med. 2019;8(12):12. doi:10.3390/jcm8122025
   Web of Science ®Google Scholar
• Alrubaiy L, Rikaby I, Sageer M, Hutchings HA, Williams JG. Systematic review of the clinical disease severity indices for inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(10):2460–2466. doi:10.1097/MIB.0000000000000438
   PubMed Web of Science ®Google Scholar
• Guo HW, Yuan TZ, Chen JX, Zheng Y. Prognostic value of pretreatment albumin/globulin ratio in digestive system cancers: a meta-analysis. PLoS One. 2018;13(1):e0189839. doi:10.1371/journal.pone.0189839
   PubMed Web of Science ®Google Scholar
• Ye Y, Chen W, Gu M, et al. Serum globulin and albumin to globulin ratio as potential diagnostic biomarkers for periprosthetic joint infection: a retrospective review. J Orthop Surg Res. 2020;15(1):459. doi:10.1186/s13018-020-01959-1
   PubMed Web of Science ®Google Scholar
• Feketea GM, Vlacha V. The diagnostic significance of usual biochemical parameters in Coronavirus Disease 19 (COVID-19): albumin to globulin ratio and CRP to albumin ratio. Front Med. 2020;7:566591. doi:10.3389/fmed.2020.566591
   PubMed Web of Science ®Google Scholar
• Park J, Kim HJ, Kim J, Choi YB, Shin YS, Lee MJ. Predictive value of serum albumin-to-globulin ratio for incident chronic kidney disease: a 12-year community-based prospective study. PLoS One. 2020;15(9):e0238421. doi:10.1371/journal.pone.0238421
   PubMed Web of Science ®Google Scholar
• Gelbmann CM. Prediction of treatment refractoriness in ulcerative colitis and Crohn’s disease–do we have reliable markers? Inflamm Bowel Dis. 2000;6(2):123–131. doi:10.1097/00054725-200005000-00009
   PubMed Web of Science ®Google Scholar
• Li K, Fu W, Bo Y, Zhu Y. Effect of albumin-globulin score and albumin to globulin ratio on survival in patients with heart failure: a retrospective cohort study in China. BMJ Open. 2018;8(7):e022960. doi:10.1136/bmjopen-2018-022960
   PubMed Web of Science ®Google Scholar
• Hodgson HJ, Jewell DP. The humoral immune system in inflammatory bowel disease. II. Immunoglobulin levels. Am J Dig Dis. 1978;23(2):123–128. doi:10.1007/BF01073186
   PubMedGoogle Scholar
• Shiraishi K, Furukawa S, Yagi S, et al. Serum globulin is associated with endoscopic findings and mucosal healing in Japanese patients with ulcerative colitis. Dig Dis Sci. 2021;67(1):233–240. doi:10.1007/s10620-021-06834-5
   PubMed Web of Science ®Google Scholar
• Xuan Q, Yang Y, Ji H, et al. Combination of the preoperative albumin to globulin ratio and neutrophil to lymphocyte ratio as a novel prognostic factor in patients with triple negative breast cancer. Cancer Manag Res. 2019;11:5125–5131. doi:10.2147/CMAR.S195324
   PubMed Web of Science ®Google Scholar
• Bozkaya Y, Erdem GU, Demirci NS, et al. Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients. Curr Med Res Opin. 2019;35(2):275–282. doi:10.1080/03007995.2018.1479683
   PubMed Web of Science ®Google Scholar
• Lin Q, Lin ZH, Chen J, et al. Prognostic significance of preoperative albumin-to-globulin ratio in patients with cholangiocarcinoma. Curr Res Transl Med. 2017;65(2):83–87. doi:10.1016/j.retram.2017.06.002
   PubMed Web of Science ®Google Scholar
• Suh B, Park S, Shin DW, et al. Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol. 2014;25(11):2260–2266. doi:10.1093/annonc/mdu274
   PubMed Web of Science ®Google Scholar
• Qin J, Qin Y, Wu Y, et al. Application of albumin/globulin ratio in elderly patients with acute exacerbation of chronic obstructive pulmonary disease. J Thorac Dis. 2018;10(8):4923–4930. doi:10.21037/jtd.2018.07.47
   PubMed Web of Science ®Google Scholar
• Hao Y, Li T, Zheng C, Jin S. The role of albumin/globulin ratio in discharged COVID-19 patients with re-positive nucleic acid detection. J Inflamm Res. 2020;13:713–717. doi:10.2147/JIR.S270305
   PubMed Web of Science ®Google Scholar
• Ahn SS, Yoo J, Jung SM, Song JJ, Park Y-B, Lee S-W. Clinical role of albumin to globulin ratio in microscopic polyangiitis: a retrospective monocentric study. Clin Rheumatol. 2018;38(2):487–494. doi:10.1007/s10067-018-4292-y
   PubMed Web of Science ®Google Scholar
• Wang Y, Li S, Hu X, et al. The prognostic value of serum albumin-globulin ratio in early-stage non-small cell lung cancer: a retrospective study. Cancer Manag Res. 2019;11:3545–3554. doi:10.2147/CMAR.S191288
   PubMed Web of Science ®Google Scholar
• Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329–342. doi:10.1038/nri3661
   PubMed Web of Science ®Google Scholar
• Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16(1):26–42. doi:10.5217/ir.2018.16.1.26
   PubMed Web of Science ®Google Scholar
• Craven MD, Washabau RJ. Comparative pathophysiology and management of protein-losing enteropathy. J Vet Intern Med. 2019;33(2):383–402. doi:10.1111/jvim.15406
   PubMed Web of Science ®Google Scholar
• Mao MJ, Wei XL, Sheng H, et al. Clinical significance of preoperative albumin and globulin ratio in patients with gastric cancer undergoing treatment. Biomed Res Int. 2017;2017:3083267. doi:10.1155/2017/3083267
   PubMed Web of Science ®Google Scholar
• Fleck A, Raines G, Hawker F, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet. 1985;1(8432):781–784. doi:10.1016/S0140-6736(85)91447-3
   PubMed Web of Science ®Google Scholar
• Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr. 2019;43(2):181–193. doi:10.1002/jpen.1451
   PubMed Web of Science ®Google Scholar
• Margarson MP, Soni N. Serum albumin: touchstone or totem? Anaesthesia. 1998;53(8):789–803. doi:10.1046/j.1365-2044.1998.00438.x
   PubMed Web of Science ®Google Scholar
• Coskun M. Intestinal epithelium in inflammatory bowel disease. Front Med. 2014;1:24. doi:10.3389/fmed.2014.00024
   PubMedGoogle Scholar
• Forbes A, Escher J, Hébuterne X, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36(2):321–347. doi:10.1016/j.clnu.2016.12.027
   PubMed Web of Science ®Google Scholar
• Lo CH, Lochhead P, Khalili H, et al. Dietary inflammatory potential and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2020;159(3):873–883 e871. doi:10.1053/j.gastro.2020.05.011
   PubMed Web of Science ®Google Scholar
• Naqvi SA, Taylor LM, Panaccione R, et al. Dietary patterns, food groups and nutrients in Crohn’s disease: associations with gut and systemic inflammation. Sci Rep. 2021;11(1):1674. doi:10.1038/s41598-020-80924-8
   PubMed Web of Science ®Google Scholar
• Hsieh MS, Hsu WH, Wang JW, et al. Nutritional and dietary strategy in the clinical care of inflammatory bowel disease. J Formos Med Assoc. 2020;119(12):1742–1749. doi:10.1016/j.jfma.2019.09.005
   PubMed Web of Science ®Google Scholar
• Eder P, Niezgódka A, Krela-Kaźmierczak I, Stawczyk-Eder K, Banasik E, Dobrowolska A. Dietary support in elderly patients with inflammatory bowel disease. Nutrients. 2019;11(6):6. doi:10.3390/nu11061421
   Web of Science ®Google Scholar
• Casanova MJ, Chaparro M, Molina B, et al. Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease. J Crohns Colitis. 2017;11(12):1430–1439. doi:10.1093/ecco-jcc/jjx102
   PubMed Web of Science ®Google Scholar
• Ling SC, Griffiths AM. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2000;3(5):339–344. doi:10.1097/00075197-200009000-00003
   PubMedGoogle Scholar
• Gassull MA. Nutrition and inflammatory bowel disease: its relation to pathophysiology, outcome and therapy. Dig Dis. 2003;21(3):220–227. doi:10.1159/000073339
   PubMed Web of Science ®Google Scholar
• Gassull MA. Review article: the role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):79–83. doi:10.1111/j.1365-2036.2004.02050.x
   PubMed Web of Science ®Google Scholar
• Mijac DD, Janković GL, Jorga J, Krstić MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med. 2010;21(4):315–319. doi:10.1016/j.ejim.2010.04.012
   PubMed Web of Science ®Google Scholar
• Chen YH, Wang L, Feng SY, Cai WM, Chen XF, Huang ZM. The relationship between C-reactive protein/albumin ratio and disease activity in patients with inflammatory bowel disease. Gastroenterol Res Pract. 2020;2020:3467419. doi:10.1155/2020/3467419
   PubMed Web of Science ®Google Scholar
• Jiang L, Xia B, Li J, et al. Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol. 2007;41(3):280–284. doi:10.1097/01.mcg.0000225644.75651.f1
   PubMed Web of Science ®Google Scholar
• Wang P, Hu J, Ghadermarzi S, et al. Smoking and inflammatory bowel disease: a comparison of China, India, and the USA. Dig Dis Sci. 2018;63(10):2703–2713. doi:10.1007/s10620-018-5142-0
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the surgeon general. Atlanta GA; 2014.
   Google Scholar
• Thomas T, Chandan JS, Li VSW, et al. Global smoking trends in inflammatory bowel disease: a systematic review of inception cohorts. PLoS One. 2019;14(9):e0221961. doi:10.1371/journal.pone.0221961
   PubMed Web of Science ®Google Scholar